Investigated for treating COVID-19.
[INH] = Inhalation; [O] = Oral.
Rebetron is ribavirin and interferon.
- TRADE NAMES: Copegus (Roche); Rebetol (Schering-Plough); Rebetron (Schering); Viramid; Virazid; Virazole (Valeant)
- INDICATIONS: Respiratory syncytial viral infections
- CLASS: Antiviral; nucleoside analog
- HALF-LIFE: 24 hours
- CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
Abacavir, Azathioprine, Didanosine, Emtricitabine, Interferon Alfa, PEG-Interferon, Stavudine, Zidovudine
RISK OF SERIOUS DISORDERS AND RIBAVIRIN-ASSOCIATED EFFECTS
See full prescribing information for complete boxed warning.
Please login to view the rest of this drug profile.
Page last updated 03/13/2024
